Viking Therapeutics
VKTX
VKTX
369 hedge funds and large institutions have $1.84B invested in Viking Therapeutics in 2025 Q1 according to their latest regulatory filings, with 65 funds opening new positions, 158 increasing their positions, 100 reducing their positions, and 100 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
369
Holders Change
-38
Holders Change %
-9.34%
% of All Funds
5.01%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
65
Increased
158
Reduced
100
Closed
100
Calls
$222M
Puts
$96M
Net Calls
+$126M
Net Calls Change
-$5.54M
Top Buyers
| 1 |
JPMorgan Chase & Co
New York
|
+$23.4M |
| 2 |
Balyasny Asset Management
Chicago,
Illinois
|
+$19M |
| 3 |
Pictet Asset Management
Carouge,
Switzerland
|
+$16.5M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$15.5M |
| 5 |
Morgan Stanley
New York
|
+$12.7M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$132M |
| 2 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$54.6M |
| 3 |
State Street
Boston,
Massachusetts
|
-$21M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$19M |
| 5 |
PA
Perceptive Advisors
New York
|
-$11.8M |
